论文部分内容阅读
所有治疗都有危险性,治疗强度越大,危险性也越大。甚至作用缓和的阿司匹林药片也可能引起消化不良和胃肠失血。然而,这些副作用轻微并且可逆,用阿司匹林治疗急性冠状血管疾病的益处远远超过其副作用。对于溶血栓制剂,利弊更加平衡。在急性心肌梗塞病人的益处必须与出血的危险相比较。自从主要试验结果发表后,用溶血栓药物如链激酶治疗已很普遍。但仔细的临床试验结果可能不一定在地区医院冠心病监护病房的每天应用中得到证实。并发症的报告已开始慢慢出现。现在应该开始清查溶血栓治疗的危险了。
All treatments are dangerous, the greater the intensity of treatment, the greater the risk. Even aspirin tablets with mild effects can cause indigestion and gastrointestinal bleeding. However, these side effects are mild and reversible and the benefits of aspirin in the treatment of acute coronary vascular diseases far outweigh their side effects. For the thrombolytic agents, the pros and cons are more balanced. The benefit of patients with acute myocardial infarction must be compared to the risk of bleeding. Thrombolytic drugs such as streptokinase have become common since the publication of the main trial results. However, careful clinical trial results may not necessarily be validated in daily use in district hospital coronary care units. The report of complications has begun to appear slowly. Now it is time to start an inventory of the risks of thrombolytic therapy.